arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

REVELATION BIOSCIENCES, INC.

REVB

$0.94 ▼ -0.02 (-1.73%) at close

27 Visible periods

18 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

REVELATION BIOSCIENCES, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $3.6M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -28.7% ↘

FCF / Share $-0.68 ↗

Trailing P/E —

Price / Book 0.4x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

27-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-3.01M

↓ -46.7% —

FCF / Share Free cash flow per share

$-0.68

↑ +33.8% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns

Cash Quality →

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
EPS Growth YoY (%)	87.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-28.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	98.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-110.7% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-36.6% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	14.2% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-3765.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-100.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-1952.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	86.1% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	99.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	99.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	—	-235.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	87.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	69.2% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-46.7% Weak ↓ Weak Declining Year-over-year change in net income	-46.7% Weak ↓ Weak Declining Year-over-year change in net income	-45.5% Weak ↓ Weak Declining Year-over-year change in net income	23.5% Good → Good Stable Year-over-year change in net income	23.5% Good → Good Stable Year-over-year change in net income	23.5% Good Good Year-over-year change in net income	21.7% Good Good Year-over-year change in net income	N/M	N/M	N/M	-82.4% Weak Weak Year-over-year change in net income	N/M	N/M	N/M	68.7% Excellent ↑ Excellent Improving Year-over-year change in net income	-153.3% Weak ↓ Weak Declining Year-over-year change in net income	-153.3% Weak ↑ Weak Improving Year-over-year change in net income	N/M	-138.0% Weak ↑ Weak Improving Year-over-year change in net income	-300862.3% Weak Weak Year-over-year change in net income	-501311.3% Weak Weak Year-over-year change in net income	N/M	—	—	—	—	—
FCF Growth YoY (%)	—	64.4% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-9.7% Weak Weak Year-over-year change in free cash flow	—	—	—	-267.9% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
FCF / Net Income (x)	0.86x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	—	1.36x Good Good Free cash flow relative to reported net income Optimal: > 1x	2.18x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	1.07x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	-0.26x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.73x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.39x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	-0.12x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.13x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	42.94x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	-2.05x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-28.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-22.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-14.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-50.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-57.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-29.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-53.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-174.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-27.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-13.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-12.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-91.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-42.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	79.7% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	5281.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	3063.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-65.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-8.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—
Return on Capital (%) (%)	-29.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-20.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-22.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-15.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-45.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-52.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-26.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-26.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-20.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-22.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-18.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-44.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-82.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-188.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	0.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—
Return on Common Equity (%) (%)	-29.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-299%)	-23.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-254%)	-28.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-289%)	-18.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-224%)	-53.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-457%)	-71.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-575%)	-36.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-344%)	-100.3% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-769%)	-235.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1668%)	-28.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-289%)	-33.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-321%)	69.8% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+366%)	54.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+260%)	61.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+310%)	-114.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-865%)	-297.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-2080%)	—	—	—	-71.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-576%)	-39.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-365%)	-26.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-274%)	28.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+90%)	-6.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-145%)	-3.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-125%)	-50.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-436%)	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Net Debt (USD)	$-11.48M	$-14.11M	$-10.70M	$-12.71M	$-5.17M	$-3.70M	$-6.50M	$-6.54M	$-12.07M	$-14.55M	$-11.99M	$-13.99M	$-15.71M	$-17.70M	$-5.25M	$-6.20M	$-3.48M	$-7.19M	$-1.27M	—	—	—	$-11.73K	$-3.32M	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Basic EPS, GAAP (USD)	$-0.87	$-2.71	$-14.19	$-1.77	$-7.01	$-2.11	$-698.11	$-0.84	$-5.13	$-2.46	$-18.06	$-0.42	$-0.25	$2.79	$-129.59	$-100.00	$-200.00	—	$-38.67	$-800.00	$-650.00	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.68	$-1.02	—	$-0.60	—	$-2.88	—	—	—	$-2.62	—	—	—	$-0.71	—	—	—	—	—	$-591.96	$-965.29	—	—	—	—	—	—
Book Value per Share (USD)	$2.58	$3.32	$5.59	$3.07	$2.49	$2.99	—	$0.62	$0.69	$5.80	—	$1.40	$1.81	$2.12	—	$157.75	$-203.65	$-10.89	$-0.35	$968.21	$1.74K	$-4.13K	$-5.21K	$9.90	—	—	—
Tangible Book Value per Share (USD)	$2.58	$3.32	$5.59	$3.07	$2.49	$2.99	—	$0.62	$0.69	$5.80	—	$1.40	$1.81	$2.12	—	$157.75	$-203.65	$-10.89	$-0.35	$968.21	$1.74K	$-4.13K	$-5.21K	$9.90	—	—	—
Basic Weighted Avg Shares (shares)	3.83M	3.21M	—	2.64M	802,670	971,313	—	2.68M	1.64M	1.09M	—	6.30M	5.81M	2.21M	—	12,633	9,050	—	—	3,775	3,775	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$9.80M	$12.79M	$8.81M	$10.98M	$3.79M	$2.84M	$4.65M	$2.59M	$1.07M	$9.40M	$6.58M	$8.75M	$11.34M	$9.93M	$962.32K	$2.13M	$-1.95M	$-207.43K	$-229.61K	—	—	$-1.61M	$-2.78M	$3.16M	—	—	$-3.64K
Total Equity (USD)	$10.07M	$12.99M	$8.86M	$11.00M	$3.83M	$2.88M	$4.71M	$2.67M	$1.14M	$9.47M	$6.65M	$8.82M	$11.41M	$10.02M	$1.05M	$2.23M	$-1.84M	$-98.51K	$-99.47K	$3.66M	$6.57M	$-4.51M	$-5.69M	$12.81K	$13.68K	$14.20K	$-3.64K

📋 What is driving earnings? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Depreciation Expense (USD)	$8.31K	$7.20K	$5.85K	$6.76K	—	$7.22K	$7.22K	$7.22K	$7.22K	$6.26K	$6.26K	$6.26K	$6.26K	$6.26K	$6.26K	$6.26K	$6.26K	$6.26K	$6.26K	$6.07K	$642.00	—	—	—	—	—	—
Net Income, GAAP (USD)	$-3.01M	$-3.01M	$-2.51M	$-2.05M	$-2.05M	$-2.05M	$-1.73M	$-2.68M	$-2.68M	$-2.68M	$-2.20M	$6.16M	$6.16M	$6.16M	$-1.21M	$-6.62M	$-6.62M	$-6.62M	$-3.86M	$-2.61M	$-2.61M	$1.18M	$-1.62M	$-868.00	$-521.00	$-7.16K	—
Operating Cash Flow (USD)	$-2.56M	$-3.21M	$-1.97M	$-1.59M	—	$-2.79M	$-3.75M	—	—	$-2.84M	$-2.00M	—	—	$-1.58M	$-947.47K	—	—	$-4.83M	$-2.88M	$-2.23M	$-3.59M	$-146.37K	$-208.12K	—	$-22.37K	$14.69K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 7 years · 27 quarters

REVELATION BIOSCIENCES, INC.

Analytical Summary

27-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare REVB with peers